NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that its Board of Directors has elected Bradley T. Sheares, Ph.D., 52, as a director, effective April 21, 2009.
